Thursday, April 29, 2021

Regional Outlook: Computer-Aided Drug Discovery Market by Key Vendors, Challenges and Opportunities 2027

 According to a study conducted by Research Dive, the global computer-aided drug discovery market forecast size is expected to reach $4,878.5 billion by the end of 2026, registering 15.5% CAGR over the forecast period.

Computer-aided drug design utilizes computational methods to analyze, develop, and discover similar biologically active molecules. The ligand-based computer-aided drug discovery (LB-CADD) method includes the understanding of ligands which are known to interrelate with a targeted disease. These procedures use a set of referral structures that are collected from compounds known to interact with the target of interest and analyze their 2D or 3D structures.ADVERTISEMENT

The rising usage of pharmaco dynamics and pharmaco kinetic modelling in pre-clinical advancements is anticipated to drive the computer-aided drug discovery markets growth in the recent years. In addition, the rapid growth in the demand for latest technologies to decrease the cost associated with drug discovery and development is the major factor for the growth of computer-aided drug discovery market.

Inspite of various positive factors, improper standardization in the drug discovery methodology has been a major point of concern. Along with the afore mentioned factor, insufficient knowledge about various biological systems and processes due to which the drug development fails are the major factor that may hamper the market growth.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/159

The global computer-aided drug discovery market is analyzed on the basis of type into Structure based drug design (SBDD), Ligand-Based Drug Design (LBDD) and Sequence-Based Approaches. Among these, the structure-based drug design market segment is expected to drive the computer-aided drug discovery market growth which is anticipated to reach $1,585.5 billion by 2026, growing at CAGR of 15.8% during the forecast period. However, LBDD segment had the highest market share in the year 2018 accounting for $606.9 billion and is expected to reach $1,878.2 billion by 2026 growing ata CAGR of 15.2% during the projected timeframe. This dominance is mainly attributed to the usage of LBDD that is the first step in developing any drug and understanding a disease molecular structure, and developing a drug suitable to resist the disease is a time taking process.ADVERTISEMENT

On the basis of the therapeutic area, the global computer-aided drug discovery market is categorized into oncology, neurology, cardiovascular disease, respiratory disease and diabetes and others. Among these, the market for oncology segment held the largest market share in 2018 accounting for $355.8 billion. Cardiovascular diseases segment is anticipated to dominate the computer-aided drug discovery market during the forecaste period. This is because the number of patients suffering from cardiovascular diseases globally is increasing. Thus, to fight the various cardio vascular diseases, the key players are investing huge in developing better and enhanced drugs.

The global computer-aided drug discovery market has been classified regionally into North America, Europe, Asia-Pacific, and LAMEA.

The North America region held the largest market value in 2018 accounting for $432.9 billion and is anticipated to reach $1,283.1 billion by 2026, growing at a CAGR of 14.5% during the forecast period.Asia-Pacific region is expected to dominate the computer-aided drug discovery market; this growth is majorly due to the growing RD expenditure by the organizations that are present in this region. The number of people suffering from various diseases in this region is also growing due to the lack of money to buy costly medicines. Asia-Pacific region accounted for $411.3 billion in 2018 and is expected to reach $1,361.1 billion by 2026, growing at a CAGR of 16.1% during the forecast period.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/download-sample/159

Top gaining participants of global computer-aided drug discovery market areBOC Sciences, Schrdinger, Aragen Bioscience, AstraZeneca, Albany Molecular Research Inc. (AMRI), BioDuro, Aris Pharmaceuticals, Charles River, Evotec A.G. and Bayers AGamong many others.These key participants are concentrating on product improvements, mergers acquisitions, collaborations and new product launches to gain majority of the market share in the overall Computer-Aided Drug Discovery industry.

Porters Five Forces Analysis for Computer-Aided Drug Discovery Market:

1. Bargaining Power of Suppliers: The key players present in this market arelimited and are catering the demand of computer-aided drug discovery due to which the suppliers power is High.

2. Bargaining Power of Consumers: The number of consumers is very highand thus the bargaining power of consumers is Low.

3. Threat of new entrants: Initial investment to setup a computer-aided drug discovery organization is very high and thus the threat of new entrants is Low.

4. Threat of substitutes: There is no alternative for computer-aided drug discovery, and thus the threat of substitutes is Low.

5. Competitive rivalry in the industry: This market includes a few market participants. Many of the key players are following similar strategies for the improvement of technologies.
The competitive rivalry in the industry is High.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Qualitative Analysis: Medical Device Manufacturing Outsourcing Market - Future Growth, Verticals, Segmentation & Forecast to 2027

 According to a study of Research Dive, the global medical device manufacturing outsourcing market forecast shall cross $104.3 million by 2026, growing at a CAGR of 10.3%.

The significant medical contract manufacturers mainly design and manufacture medical devices along with the provided services such as UV bonding, injection molding, and other manufacturing services to the larger-sized OEMs and medical device companies. Massive increase in the geriatric population,growing global demand for the life expectancy and tremendously booming demand for technological advances particularly in the medical device industries, are some of the key factors projected to drive the medical device manufacturing outsourcing market growth. For example, as per research conducted by UN (United Nations), in 2019, around 703 million people were of 65 years of age or over, across the globe. Furthermore, the number of aged people is expected to reach upto 1.5 billion (double) in 2050. Moreover, the massive growth in availability of healthcare and increasing number of patients across the globe are also driving the medical device manufacturing outsourcing market growth.ADVERTISEMENT

In addition, the rapidly rising burden of chronic diseases worldwide, is also making positive impact on the growth of medical device manufacturing outsourcing market. For instance, As per data of WHO(World Health Organization), by 2020, the proportion of the burden of chronic disease like NCDs is anticipated to boost upto 57%, across the globe. On the other hand, the risk of leak of confidential data can be the obstruction to the growth of medical device manufacturing outsourcing market.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/download-sample/165

To meet the huge demand for healthcare emerging industries, the governments of china and India are focusing more on the enactment of policies such as Healthy China 2030 Plan and National Health Protection Mission. Also, rapid enhancements in the quality of healthcare sector in emerging economies are projected to generate huge opportunities of the medical device manufacturing outsourcing market. Developing countries such as India are projected to increase healthcare expenditure mainly because of extensively growing patients of non-communicable diseases (NCDs) diabetes and cancer. So these countries are emphasizing mainly on implementation of effective solutions and strategies to close gaps in healthcare industries. In addition, growing income and swiftly growing urbanization among these countries are projected to upsurge the medical device manufacturing outsourcing market.ADVERTISEMENThttps://ae1d9a351da1aa99541da38eb565d790.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html

The IVD(in-Vitro Diagnostic) device segment shall generate a revenue of$14.0 million by the end of 2026, increasing at a CAGR of 9.8%, over the forecast period.

The IVD (in-Vitro Diagnostic) devices segment has a significant market share over the projected period. Significantly increasing demand for early as well as accurate disease diagnosis, rising demand for FA instruments and automation in laboratories, and boosting adoption of PoC testing, are the major factors driving the medical device manufacturing outsourcing market. In addition, massive growth in the number of medical institutions in developing economies is also anticipated to generate noticeable revenue in this market.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/165

The global device development and manufacturing services market has a highest market share, and it shall register a revenue of $35.6 million by 2026, increasing at a CAGR of 9.7%.The development and manufacturing services has the highest market share, over the projected period. High initial expenditure for in-house production of medical devices and positive growth in the medical device sector is expected to boost the development and manufacturing services segment growth.

The class II medical devices segment shall register a revenue of $38.1 million by the end of 2026, increasing at a CAGR of 10.0%, during the forecast period. The class II medical device is specifically non-invasive and mainly consists of remote health care monitoring device, medical lasers, and many other devices. Also, significant contract medical device manufacturing companies like Cogmedix are supporting innovative companies to bring new class II devices to the global market.These factors are projected to surge the growth of medical device manufacturing outsourcing market.

The Asia-Pacific medical device manufacturing outsourcing market will cross $32.3 million by 2026, increasing at a healthy CAGR of 9.5%.

Asia-Pacific has the major share during the projected period mainly because of existance of a large base of chronic diseases cases, drastic developments in the technological knowledge, cost-effective labors. In addition, Asian economies like India, Japan and China have enormous market opportunities for pharmaceutical manufacturing. Also, the Korean based key players like Nissha Co., Ltd. are emphasizing majorly on a flexibility and customer-based service. These above mentioned factors are anticipated to boost the medical device manufacturing outsourcing market growth.

North America medical device manufacturing outsourcing market is the fastest growing market and it is expected to grow at a CAGR of 10.8% by generating revenue of $31.2 million by 2026. Tremendously rising demand for medical requirement, along with rising capital expenditure on healthcare are signifacant factors for boosting the North American medical device manufacturing outsourcing market growth. For example, according to American Medical Association, the U.S. has spent almost $3.5 trillion on the healthcare sector in 2017. These factors further drive the demand for medical devices, which eventually is going to surge the growth of medical device manufacturing outsourcing market in the North America region.

The major medical device manufacturing outsourcing market manufacturers areCreganna, Tecomet, Inc., Mitutoyo Corporation, FLEX LTD., Integer Holdings Corporation, Nortech Systems, Inc., Hamilton Company., DAIICHI JITSUGYO CO., LTD., Kinetics Climax Inc., andCirtec.To elaborate more on the competitive landscape analysis of top market players, the porters five force model is explained in this report.

Porters Five Forces Analysis for Medical device manufacturing outsourcing market:

Bargaining Power of Suppliers: Established suppliers in the healthcare industry use their negotiating power to extract high prices. Moreover, the switching costs from one supplier to another supplier is projected to be high.
The bargaining power of suppliers is HIGH.

Bargaining Power of Buyer: Hospitals and other healthcare institutions buy medical devicesin bulk quantities and apply pressure on pharmaceutical ventures to keep prices in check.
The bargaining power of consumers is MEDIUM.

Threat of New Entrants: High cost associated with RD along with government regulatory constraints provide slow threat of entry from new or potential competitors.
The threat of new entrants isLOW.

Threat of Substitutes: The threat of a substitute product is high if it provides a value proposition that is significantly different from the present service of the market.
The threat of substitutes is LOW.

Competitive Rivalry in the Market: Medical device manufacturing outsourcing market contains numerous small, medium, and large ventures. Leading enterprises are following alternative business strategies and technological advances among them is also a significant factor for the high competitive rivalry in the global market.
The competitive rivalry in the industry is HIGH.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Corona Impact: Is Utility Poles Market will Propel with its Advanced Approaches in 2020

 The spread of COVID-19 virus all over the world has negatively impacted the global utility poles market. Nevertheless, the market is likely to recover by Q3/Q4 of 2022. The decline in the market growth is mainly due to the shutting down of many industries all across the globe. Governments of various countries are taking initiatives in this unprecedented to provide electricity to the people. For example, the government of Kenya is launching various plans to provide free electricity to all the residents by 2022.

The global utility poles market is likely to observe a decline in the growth rate due to the COVID-19 pandemic all over the world. According to a new report added to Research Dives offerings, the global utility poles market is estimated to reach up to $55,360.7 million and grow at a CAGR of 2.7% during the forecast period from 2019 to 2026. Though there is a decline in the growth rate, the industry is projected to recover by Q3/Q4 of 2022. Comprehensive analysis on drivers, restraints, growth opportunities, key segments, and strategies executed by major market players are further provided in the report to wisely understand the pandemic effect on the global market.ADVERTISEMENT

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/282

Key Features of the Market

Our analysts stated that the rising use of poles in electricity and telecommunication sectors are the major factors estimated to boost the growth of global utility poles market during the forecast period. The predicted market size of the global utility poles market post COVID-19 pandemic is $28,296.0 million in 2020, which is a drastic decline from $47,159.9 million before the pandemic situation. However, the shutting down of various industries due to COVID-19 spread and the stringent government rules and regulations are the factors restricting the market growth. On the contrary, the improvements in distribution and transmission network in several regions and growing investments in the power sector are expected to create massive growth opportunities in the global market.

Strategies Initiatives to Sustain in the Pandemic

Abrupt stop at construction sites and decreasing use of electricity have impacted the utility poles market to a large extent. The governments of various countries across the globe are under complete lockdown in order to prevent the spread of COVID-19 disease and are investing more in power sector. For instance, the government of Kenya is executing various plans to provide free electricity to the residents by the end of 2022.ADVERTISEMENThttps://de73e6ccdd733e68571b94daf733076e.safeframe.googlesyndication.com/safeframe/1-0-38/html/container.html

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/282

Government is making improvements in construction operations to sustain in this pandemic situation. The governments of many countries have made it a mandate for the buyers to buy electric appliances from government shops in order to help the economic growth of the country. For instance, the government of India has asked the buyers of electricity industry, and DISCOMs, to help countrys economic growth by purchasing the items for the construction purposes. Moreover, many developed countries such as the U.S. are significantly taking more efforts to implement large-scale debt driven measures as compared to the governments of developing countries.

The major players of the global utility poles market include Hill Smith Holdings Plc, El Sewedy Electric Company, KEC International, Skipper Ltd., Valmont Industries Inc., Omega Factory, Pelco products Inc., Nippon Concrete Industries Co. Ltd., Stella-Jones, FUCHS Europoles GmbH, and RS Technologies Inc.

Post-Pandemic Scenario

As per the report, the global utility poles market is anticipated to observe a significant growth post-coronavirus pandemic. The growing demand for utility poles owing to the establishing real-time competitive market for electricity and its supply will help the industry to grow exponentially during the forecast period. Besides, the acceptance of composite materials in these poles and their cost-effective nature will boost the growth of the global utility poles market after the end of COVID-19 pandemic.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

COVID-19 Impact Review: What Challenges Aluminum Fishing Boat Market May See In Next 5 Years?

 The COVID-19 pandemic is foreseen to impact the global aluminum fishing boat market is a pessimistic way. Multi-species boat type will rise with healthier rate of revenue in the global market share. >16-feet size boat segment is foreseen to garner a considerable amount of the global market share. 200-300 HP segment will prosper with healthier rate in the forecast time period. In light to region, Europe region has dominated the global market share.

The world is facing an unpredicted change and many of the industries are experiencing thought galling situation due to the COVID-19 pandemic. The COVID-19 outbreak has negatively impacted the global aluminum fishing boat market. Rising interest for fishing among the people and increasing advantage from the consumption of seafood. In addition, aluminum boats offer advantages such as the ability to inhibit corrosion, robustness, and compatibility. These are the factors considerable for the market growth in the forecast period of time. During this coronavirus crisis situation, we are helping our clients in understanding the impact of COVID-19 on the global aluminum fishing boat market.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/download-sample/230

Our report includes:
• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

According to a new report published by Research Dive, the global aluminum fishing boat market is foreseen to produce revenue of $1,811.7 million by 2026, at a CAGR of 6.8% in the forecast time period from 2019 to 2026.

The global aluminum fishing boat market has been fragmented on the basis of body type, size, horse-power, and region. The report provides detailed information about drivers, opportunities, restraints, segmental analysis and competitive players of the market. As per our analysts,increased demand for fishing coupled with the growing concern among the people about sea food consumption has influenced strongly on the market growth in the forecast period.

Multi-Species Boat Segment has Dominant Market Share

Considering boat type, the overall market is bifurcated into deep-v-boat, bass boat, multi-species boat, and others. Among these, multi-species boat segment dominated the market in the year 2018 and is expected to contribute for $222.8 million in 2026. Multi-species boats offer range of benefits such as it can be utilized in both type of water i.e., fresh and salt water.

>16-Feet Segment Will Grow at a Significant Rate Throughout the Forecast Years

On the basis of size, the global aluminum fishing boat market is segmented into<14-feet, 14-16-feet, and >16-feet. The market for >16-feet segment will witness to rise at a faster rate of 7.8% CAGR and is predicted to register for $568.9 million till the end of 2026. This size aluminum boat offers dual side rod storage space, large casting deck, and it can be used for shallow water.

200-300 HP Segment Will Grow at a Significant Rate throughout the Forecast Years

In view of horse power, the aluminum fishing boat market is classified into <200 HP, 200-300 HP, and >300 HP boats. The market for 200-300 HP segment will witness to rise at a faster rate of 7.9% CAGR and is predicted to register for $570.7 million till the end of 2026. 200-300 Hp boats offers more acceleration and less fuel consumption as compared to other horse power boats.

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/230

Regional Outlook and Major Market Players

The global aluminum fishing boat market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among these, Europe market has dominated the global market share, and is estimated to reach up to $434.8 million till 2026. Europe region has dominated global market share due to increasing freshwater boating activities. According to some publication, people give more preference for freshwater boating activity rather than sea water boating.

The most prominent players in the global aluminum fishing boat market are Mercury Boats, CrestlinerNautischeUnie, Lund Boats, UMS Tuna Boats, Yamaha Motor Company, Correct Craft, White River Marine Group, Telwater, Brunswick Corporation, Smoker Craft Inc., and other.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Is Coagulation Testing Market Trapped Between Growth Expectations And Uncertainty?

 The COVID-19 outbreak had a huge impact on the overall market for coagulation testing. The Instruments products type will be the most lucrative. The Asia-Pacific region will have good opportunities. The key players are developing strategies to achieve a competitive advantage in the industry.

As per the report by Research Dive, the global coagulation testing market is expected to reach up to $3,814.3 million by 2026, and to grow to 7.1% in the forecasted period between 2019 and 2026.

COVID-19 outbreak has had a major impact on the coagulation testing market, and it is anticipated that there will be significant market growth. New research indicated that the main cause of deaths in COVID-19 patients with severe disease is coagulation dysfunctions. This coagulation dysfunction occurs primarily because of acute respiratory failure and coagulation of the blood (thrombosis).

Connect with Analyst to Reveal How COVID-19 Impacting On Market: https://www.researchdive.com/connect-to-analyst/254

Furthermore, in the COVID-19 outbreak period, many governments are taking various initiatives to support companies. The People’s Liberation Army Professional Committee of Critical Care Medicine and Chinese society, have come together to establish an expert consensus on coagulation dysfunction treatment and diagnosis related to a severe COVID-19 virus. In this time of crisis, these factors significantly drive market growth.

Highlights of the Report:

The global coagulation testing market has witnessed remarkable growth in the previous years. The sudden outbreak of coronavirus has impacted the market, bringing even more chances of growth. As per the report, the global coagulation testing market industry is expected to register a revenue of $3,814.3 million by 2026, at a growth rate of 7.1% during the forthcoming years. In the current situation, the market has garnered $2,555.1 million owing to the importance of coagulation testing therapies during the complete shutdown.

Factors Impacting the Market Growth amidst Covid-19 Pandemic

The benefits of coagulation testing, as well as the common use of coagulation testing treatments for hematology and thrombosis in hospitals and clinical laboratories, will drive the markets in the projected period. Conversely, the prohibitive cost of testing coagulation limits the market growth. Furthermore, the lack of skilled testing for coagulation and the use of analyzers could impede the industry’s growth.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/254

Current Market Transformation Due to Covid-19:

The current state of the market

The COVID-19 pandemic impacted the overall test-coagulation market positively. The analysis of a series of coagulation tests (PET) is carried out by researchers in the susceptibility tests of COVID-19 patients, such as platelet, fibrinogen, and dimer. There have been reports that patients with higher rates of D-dimers are more likely to face death. Many other government officials have taken a variety of steps to promote businesses during the pandemic. The Chinese government, for example, recently unveiled a new series of technical innovations to support new vertical business growth structures such as cloud, internet, industrial internet, and SOE technology. The government has decided to improve technology in the areas of telemedicine, life sciences, pharmaceutics, and pharmacy. However, the high costs associated with diagnosis and study should constrain market growth. Furthermore, the lack of qualified coagulation tests and the use of analyzers could also hamper industry growth.

Post-pandemic Market Insights:

As per the report, there are plans to maintain sustainable growth after the pandemic in the global coagulation test market. It is expected that in the coming few years, some of the leading market players will bring innovative progress and rewarding opportunities to the market. Some of these key players include Helena Laboratory Corporation, Thermo Fisher Scientific Inc., Micropoint Biosciences, F. Hoffmann La Roche Ltd, Medtronic, NIHON KOHDEN CORPORATION, Sysmex Corporation, Abbott and Danaher, among others.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

How Cancer Stem Cells Market Will Grow In Coming Future Despite COVID-19 Chaos?

 The COVID-19 pandemic is expected to impact the global cancer stem cells market in a positive way. Bladder cancer segment will flourish with healthier rate of revenue in the global market. Targeted cancer stem cells application segment is foreseen to gather a considerable amount of the global market share. Considering regions, Asia-Pacific region has dominated the global market share in the forecast period.

The world is facing an unexpected change and many of the industries are experiencing thought provoking situation due to the COVID-19 pandemic. The COVID-19 outbreak has positively impacted the cancer stem cells market. Many government bodies are investing money for research & development activities to enhance the utilization of cancer stem cells for the treatment of cancer cells.In addition, development of stem cells for stem line banking and developing induced pluri-potent stem cell (PSC) lines can be done for treatment of broad range of diseases from diabetes to arthritis. During this coronavirus crisis situation, we are helping our clients in understanding the impact of COVID-19 on the cancer stem cells market.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/203

Our report includes:
• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

According to a new report published by Research Dive, the global cancer stem cells market is projected to generate a revenue of $1,898.3 million by 2026, at a CAGR of 11.8% in the forecast time from 2019 to 2026.

The global market segmentation has been done on the basis of cancer forms, application, and region. The report provides detailed information about drivers, opportunities, restraints, segmental analysis and competitive players of the market. As per our analysts, increased risk of cancer around the world and increased trend among youth for smoking is increasing the risk of cancer, which is significantly driving the market growth.

Bladder CancerSegment has Dominant Market Share

Based on cancer forms, the overall market is segmented intobreast, blood, lung, brain, colorectal, pancreatic, bladder, liver, and other. Among these, bladder cancer segment dominated the market in the year 2018 and is expected to register for $303.9 million in 2026. Deaths around the world due to bladder cancer account for nearly 150,000 per year. Many other treatments such as systemic immunotherapy, radiotherapy, and chemotherapy are used to treat but treating bladder cancer by utilization of cancer stem calls has resulted in positive outcome. According to the U.S. government, bladder cancer is the fifth most occurring cancer amongall other cancer types and thus positive impact of CSCs in the treatment will accelerate the growth of the market in the projected time.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/203

Targeted Cancerous Stem Cells Application Will Grow at a Significant Rate Throughout the Forecast Years

On the basis ofapplication, the cancer stem cells market is classified into stem cells cancer therapy and targeted cancerous stem cells. The market for targeted cancerous stem cells application segment will witness to rise at a rate of 13.0% CAGR and is predicted to register for $910.0 million till the end of 2026. Targeted cancerous stem cells have the potential to attract normal cells and can be utilized positively to target cancer cells owing to the interaction between normal cells and CSCs, resulting in reduced inflammation, angiogenesis, and tumor proliferation. These factors will fuel the market size in the forecast time.

Regional Outlook and Major Market Players

Asia-Pacific market has dominated the global market share, and is estimated to reach up to $405.1 million till 2026. This dominance is attributed due to thepresence of significant number of associations actively engaged in the R&D of stem cell therapy. Asia-Pacific cancer stem cells market will experience a remarkable growth and projected to generate revenue of $405.17 million by the end of 2026, at a CAGR of 12.8%. This expected rise in the Asia-Pacific market is majorly due to funding agencies are providing permission to research associations to accelerate their R&D on cancer stem cells in other Asian countries and this aspect is predicted to boost the market growth in the projected time.

The most prominent players in the global cancer stem cells market include Thermo Fisher Scientific Inc., Merck KGaA, AbbVie Inc., Stem Cell Technologies Inc., Irvine Scientific, OncoMed Pharmaceuticals, Sino Biological Inc., BioTime Inc., MiltenyiBiotec and others.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

COVID-19 Outbreak: How Plasma Therapy Market Will Shape Having Biggies with Strong Fundamentals?

 The Covid-19 pandemic is projected to have a positive influence on the global plasma therapy market. This is because scientists are majorly considering the plasma therapy technique as a possible treatment for treating this novel disease. The autologous source segment and Pure Platelet-Rich Plasma (PRP) segment of this market are foreseen to garner a considerable growth and lead the market during estimated period. Moreover, the Asia-Pacific region is expected to perceive outstanding growth and engender rewarding growth opportunities during the forecast period. The major players of the market are undertaking various strategies to withstand during this havoc period.

This sudden outburst of coronavirus pandemic has imposed an optimistic impact on the global plasma therapy market. This market is anticipated to observe significant growth during this pandemic period. Currently, scientists from various parts of the world are concentrating on numerous possibilities to invent an effective treatment or vaccine that can combat this life-threatening disease. Researchers are majorly considering the plasma therapy technique as a possible treatment for this disease. This factor is considerably boosting the demand for plasma therapy for the treatment of COVID-19 disease, thus boosting the market growth during the pandemic period.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/204

In the course of this turmoil condition, we are helping our patrons in understanding the influence of COVID-19 on the plasma therapy market.

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

The global plasma therapy market is foreseen to garner $432.8 million by 2026, growing at a healthy growth rate of 16.3% from 2019 to 2026, reveals a new research study published by Research Dive.

The report segments the global market into type, source, application, end use, and region. The study offers comprehensive analysis of drivers, opportunities, restraints, vital segments, and top market players.

Factors Propelling Market Growth

As per the report, cumulative demand for plasma treatment for curing neurological disorders & orthopedic conditions, and growing awareness about dental health & personalized healthcare systems are greatly boosting the growth of the global market. On the other hand, high expenses involved in plasma therapy is a prime restraint for the growth of the plasma therapy market.

Pure Platelet-Rich Plasma (PRP) Segment to Dominate the Market

By types, the report divides the global market into pure platelet-rich plasma (PRP), leucocyte-rich PRP, leukocyte-rich fibrin, and pure platelet-rich fibrin. Among these, the pure PRP segment was valued at $50.1 million in 2018 and is expected to grow at a healthy growth rate of 16.7% during the projected period. This growth is mainly attributed to the growing usage of pure PRP in the treatment of neurosurgery, cosmetic surgery, orthopedics/spinal surgery, and others due to its cost effectiveness compared to other treatments.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/204

Autologous Source Segment to Lead the Market

Based on source, the report classifies the global market into allogeneic and autologous. Among these, the autologous source segment is expected to garner $298.6 million by 2026. This segment is expected to have strong dominance over the market because autologous biologics plays a major role in tissue repair and generation treatments and helps in enhancing the healing power of chronic and recalcitrant wounds.

Regional Breakdown of the Market

Regionally, the report evaluates the global market across North America, Europe, Asia Pacific, and LAMEA. Among these, the North American region grabbed the largest share of plasma therapy market in 2018 and is expected to gather $155.8 million revenue by 2026. This is mainly owing to the development of advanced protein fractioning procedures and cumulative demand for plasma therapy techniques from clinics and hospitals in this region. Moreover, the Asia-Pacific region is expected to observe notable growth and generate rewarding growth opportunities during the estimated period.

Major Market Players

The leading players in the global plasma therapy market are Kedrion S.p.A, Grifols, S.A., Cambryn Biologics, LLC, CSL Limited, Bio Products Laboratory Ltd, BioLife PLASMA SERVICES, Octapharma AG and China Biologic Products Holdings, Inc., Biotest AG, and others. These players are applying several business ploys such as mergers and acquisitions, collaborations & partnerships with an aim to gain a major market share in the global industry.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Wednesday, April 28, 2021

Corona Impact: Is Computer Aided Drug Discovery Market will Propel with its Advanced Approaches in 2020

 The coronavirus outbreak is predicted to impact the global computer aided-drug discovery market in a positive way. The ligand-based drug design segment (LBDD) is estimated to hold a dominant share in the global market. By therapeutic area, the respiratory disease segment will be most lucrative during the period of forecast. The Asia Pacific region is anticipated to grow at the highest CAGR by the end of 2026. The prominent players of the industry are focusing on various strategies to hold a strong market position amidst the pandemic stress.

The impact of COVID-19 pandemic has left the world in the biggest shock of this decade. The number of people suffering due to the Corona virus has been increasing at a rapid pace. Many medical organizations across the globe are working meticulously on developing the vaccine for COVID-19. Furthermore, several organizations are coming together to use their respective specializations and develop a drug that can fight this pandemic situation. For instance, Vir Biotechnology and National Institute of Health Vaccine Research Centre has formed a partnership to understand the immune responses of various drugs on COVID-19. Government bodies are investing generously in order to support the development of drugs; for instance, Three Oxford based COVID-19 projects have received an investment of $24.63 billion from the government of UK.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/208

Companies are investing hefty amounts in developing various drugs and software that can simplify and help the process of drug discovery; for instance, AlphaFold, an AI system introduced by Google, is helping the organizations in understanding the 3D structure of a protein-based on the genetic sequence of the virus. At present, the COVID-19 pandemic is boosting the global computer-aided drug discovery market growth and is expected to upsurge the market growth in the coming years as well. During this unique situation, our analysts are helping our clients in understanding the impact of COVID19 on the computer aided-drug discovery market by providing them with an in-depth analysis.

Our report includes:

• Technological Impact
• Social Impact
• Investment Opportunity Analysis
• Pre- & Post-COVID Market Scenario
• Infrastructure Analysis
• Supply Side & Demand Side Impact

As per a latest report published by Research Dive, the global computer aided-drug discovery market is set to generate a revenue of $5,427.2 billion by 2026, at a CAGR of 16.9% during the forecast period from 2019 to 2026.

The market has been segmented on the basis of type, therapeutic area, end-user, and region. The computer aided-drug discovery report provides in-depth insights on drivers, vital segments, opportunities, restraints, and key players of the market. As per our analysts, rising healthcare expenditure all across the globe is expected to drive the global computer aided-drug discovery market. However, high cost and time consumption associated with developing new drugs is expected to hamper the market growth.

Ligand-Based Drug Design Segments to Have Dominant Share

Based on type, the global computer aided-drug discovery market is classified into structure-based drug design (SBDD), ligand-based drug design (LBDD), and sequence-based approaches. The ligand-based drug design segment accounted for $606.9 billion in revenue in 2018 and is projected to grow at 16.6% CAGR by the end of 2026. Ligand is the process that is being used widely, as it is the first stage in the development of drugs. Structure-based drug design requires ligand structures for developing the drugs further.

Download Exclusive Free Sample Copy of the Report at: https://www.researchdive.com/download-sample/208

Respiratory Disease to be Most Lucrative

Based on therapeutic area, the global market for the computer aided-drug discovery is classified into oncology, neurology, cardiovascular disease, respiratory disease, diabetes, and others. The market size for the respiratory disease accounted for $243.4 billion in 2018 and is estimated to grow with the highest CAGR of 17.3% CAGR by 2026. This growth is attributed to the rapid rise in respiratory issues that are being observed in patients suffering from COVID-19.

Pharmaceutical Companies to be Most Lucrative

On the basis of end-user, the computer aided-drug discovery market is divided into pharmaceutical companies, biotechnology companies, research institutes, and others. Pharmaceutical company segment is anticipated to dominate the global computer aided-drug discovery market. Pharmaceutical company vertical accounted for $452.9 billion in 2018 and is projected to grow with a CAGR of 17.2% during the projected time frame. The growth is majorly owing to the growing necessity for an appropriate drug for fighting COVID-19 disease.

Geographical Analysis and Major Market Players

Based on the region, the global computer aided drug discovery market is segmented into North America, Europe, Asia Pacific, and LAMEA. The Asia-Pacific computer aided-drug discovery market accounted for $411.3 billion in 2018 and is anticipated to rise at 17.6% CAGR throughout the forecast period. The growth is majorly attributed to the growing R&D expenditure by pharmaceutical and biotechnology companies.

The major players of the global computer aided drug discovery market include BOC Sciences, BioDuro, Schrödinger, Aris Pharmaceuticals, Aragen Bioscience, Albany Molecular Research Inc. (AMRI), Charles River, AstraZeneca, Evotec A.G., and Bayers AG.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com

Tuesday, April 27, 2021

Emerging Trends: Lottery Market Scope by Demand, Trends to Expand Significantly by 2027

 The abrupt occurrence of COVID-19 has created a negative impact on the development of the global lottery market. The market is estimated to pull through the incurred losses by the second or third quarter of 2022.

The latest research report on the global lottery market by Research Dive deliberates the influence of COVID-19 pandemic on the present and future growth of the global market. This report is professional and comprehensive research formulated by specialists by evaluating top driving factors, major regional market situations, opportunities & future scope, and trends & developments in the market during the COVID-19 catastrophe.

Connect with Our Analyst to Contextualize Our Insights for Your Business: https://www.researchdive.com/connect-to-analyst/311

Highlights of the Report:

The global lottery market has perceived remarkable growth in the previous years; however, the sudden rise of the COVID-19 pandemic has negatively impacted the growth of the market.

As per the report, the global lottery market was valued at $157.7 million in 2018 and was expected to garner a revenue of $351.8 million by 2026, growing at a CAGR of 10.6% in the forthcoming years. In the current situation, the market size has reached $115.0 million owing to the implementation of lockdown and shutdown of the casinos.

Market analysts have predicted that the market is likely to restore from the incurred losses and grow considerably by the second or third of 2023.

Factors Hindering the Market Growth amidst Covid-19 Pandemic

The enforcement of lockdown in various parts of the world has ceased functioning and disrupted the growth of the market. Hence, a severe downfall in revenue generation has been observed in 2020, which is hampering the growth of the global lottery market. However, the market is predicted to observe a significant rise once the COVID-19 pandemic ends and the functioning of gambling houses resumes.

Current Market Transformation Due to Covid-19:

The key players in the lottery market are experiencing a shift towards the online channels for gambling due to the shutdown of numerous casinos and gambling dens. For Example, BetBuddy has introduced a compulsive behavior recognition AI bundle which accurately targets the user to circulate more money.

During this emergency, market players are using several business tactics to withstand their business. Some of the leading players active in this market are INTRALOT, Camelot Group, Francaise des Jeux, Loterías y Apuestas del Estado, Mizuho Bank Ltd., Singapore Pools, Hong Kong Jockey Club, Florida Lottery, California Lottery, and others.

Download Exclusive Sample Copy of the Report at: https://www.researchdive.com/connect-to-analyst/311

Post-pandemic Market Insights:

As support to help businesses survive during the COVID-19 crisis, government bodies are implementing significant schemes for promoting industries. The emerging technological advancements and enormous adoption by the leading players in the digital platforms are expected to open up significant market growth opportunities in the years to come.

Furthermore, the growth for the lottery market post-OCOVID-19 will be powered by artificial intelligence and machine learning in lottery applications. A lottery is deemed the world’s most common form of gambling. In addition, the blockchain technology that provides open and confidential transaction transparency is projected to generate more chances in the prediction era.

To support new clients with state-of-the-art technology developments, Intralot is combing emerging technologies and innovations with its products. Firelotto is seeking to revolutionize the lottery market, which provides accessible and fully opens 24/7 lottery parameters in open source.

Abouat Us:

Research Dive is a market research firm based in Pune, India. Maintaining the integrity and authenticity of the services, the firm provides the services that are solely based on its exclusive data model, compelled by the 360-degree research methodology, which guarantees comprehensive and accurate analysis. With unprecedented access to several paid data resources, team of expert researchers, and strict work ethic, the firm offers insights that are extremely precise and reliable. Scrutinizing relevant news releases, government publications, decades of trade data, and technical & white papers, Research dive deliver the required services to its clients well within the required timeframe. Its expertise is focused on examining niche markets, targeting its major driving factors, and spotting threatening hindrances. Complementarily, it also has a seamless collaboration with the major industry aficionado that further offers its research an edge.

Contact Us:

Mr. Abhishek Paliwal
Research Dive
30 Wall St. 8th Floor, New York
NY 10005 (P)
+ 91 (788) 802-9103 (India)
+1 (917) 444-1262 (US) Toll
Free : +1 -888-961-4454
Email: support@researchdive.com